sarscov
spike
glycoprotein
main
target
protect
immun
respons
human
anim
model
sar
demonstr
effici
express
wildtyp
spike
gene
cultur
cell
requir
use
improv
plasmid
vector
contain
donor
acceptor
splice
site
well
heterolog
viral
rna
export
element
cte
mazonpf
monkey
viru
pre
woodchuck
hepat
viru
wpre
presenc
splice
site
wpre
markedli
improv
immunogen
sbase
dna
vaccin
sar
upon
immun
mice
low
dose
nake
dna
intron
wprecontain
vector
could
induc
neutral
anti
antibodi
provid
protect
challeng
sarscov
observ
like
use
construct
plasmid
viral
vector
design
optim
express
intronless
gene
deriv
cytoplasm
rna
virus
mechan
sarscov
introduct
human
larg
unknown
sarscovlik
virus
isol
cage
himalayan
palm
civet
raccoon
dog
liveanim
market
china
guan
et
al
kan
et
al
evid
direct
transmiss
sarscovlik
virus
anim
human
report
chines
sar
molecular
epidemiolog
consortium
howev
recent
studi
suggest
civet
may
serv
amplif
host
sarscov
exist
upstream
wild
anim
reservoir
propos
tu
et
al
wu
et
al
consist
hypothesi
sarscov
like
virus
share
nucleotid
ident
sarscov
isol
horsesho
bat
mainland
china
hong
virolog
wwwelseviercomlocateyviro
kong
sar
lau
et
al
thu
reemerg
sarscov
matter
concern
effici
vaccin
would
effect
way
control
new
epidem
similar
coronavirus
sarscov
envelop
positivestrand
rna
viru
larg
singlestrand
genom
kb
length
encod
replicas
polyprotein
small
accessori
protein
four
major
structur
protein
nucleoprotein
n
small
envelop
protein
e
membran
protein
larg
clubshap
spike
protein
sarscov
spike
protein
typei
transmembran
glycoprotein
consist
amino
acid
aa
molecular
weight
kda
predict
sequenc
analysi
consist
four
domain
signal
sequenc
aa
larg
ectodomain
compris
aminoacid
potenti
nglycosyl
site
transmembran
domain
aa
short
cytoplasm
tail
aa
rota
et
al
protein
mediat
mani
biolog
properti
viru
includ
viral
entri
bind
cellular
receptor
lsign
jeffer
et
al
penetr
fusion
viral
cellular
membran
matsuyama
et
al
petit
et
al
simmon
et
al
also
associ
host
rang
tissu
tropism
girogl
et
al
qu
et
al
coronavirus
casai
et
al
haijema
et
al
kuo
et
al
protein
sarscov
candid
antigen
vaccin
develop
main
target
neutral
antibodi
human
patient
nie
et
al
temperton
traggiai
et
al
moreov
passiv
immun
studi
demonstr
spikespecif
neutral
antibodi
protect
mous
ferret
ter
meulen
et
al
anim
model
accordingli
sever
candid
vaccin
reli
induct
spikespecif
neutral
antibodi
report
induc
protect
immun
respons
variou
anim
model
bisht
et
al
bisht
et
al
buchholz
et
al
bukreyev
et
al
chen
et
al
yang
et
al
effici
express
intronless
gene
plasmid
viral
vector
may
requir
presenc
addit
cisact
regulatori
modul
within
express
cassett
splice
site
ss
retrovir
constitut
transport
element
cte
hepadnavir
posttranscript
regulatori
element
pre
studi
latter
viral
element
cte
masonpf
monkey
viru
mpmvcte
rizvi
et
al
pre
woodchuck
hepat
viru
wpre
donello
et
al
success
use
purpos
loeb
et
al
tan
et
al
wodrich
et
al
zufferey
et
al
howev
optim
choic
posttranscript
enhanc
modul
depend
type
cdna
express
whether
strategi
may
appli
express
gene
cytoplasmrepl
rna
virus
mrna
natur
process
splice
nuclearexport
machineri
remain
determin
present
studi
report
construct
seri
dna
express
vector
contain
wildtyp
code
sequenc
influenc
ss
mpmvcte
wpre
express
protein
transfect
cell
induct
protect
sarscovspecif
immun
mice
nake
dna
immun
compar
found
wpre
togeth
ss
allow
effici
express
cell
wherea
cte
slight
moder
effect
depend
cell
line
furthermor
dose
rang
experi
demonstr
administ
mice
dna
plasmid
vector
wpre
induc
highest
level
anti
antibodi
protect
toward
challeng
live
sarscov
code
region
sarscov
protein
amplifi
rtpcr
bronchoalveolar
lavag
patient
hospit
probabl
sar
french
hospit
vietnam
clone
pci
express
vector
control
cytomegaloviru
cmv
immediateearli
promot
yield
pcdna
pci
plasmid
respect
see
fig
initi
test
protein
express
driven
vector
transient
transfect
vero
cell
permiss
sarscov
replic
thu
allow
matur
express
essenti
sarscov
gene
pcdna
induc
detect
level
protein
either
immunoblot
use
sspecif
rabbit
antiserum
fig
lane
indirect
immunofluoresc
data
shown
due
inadequ
sensit
detect
method
sinc
fig
transient
express
sarscov
spike
protein
follow
plasmid
dna
transfect
subconflu
monolay
vero
cell
transfect
empti
express
plasmid
h
posttransfect
whole
cell
extract
prepar
laemmli
sampl
buffer
separ
sdspage
indic
lane
analyz
western
blot
describ
materi
method
use
rabbit
polyclon
antibodi
direct
protein
altern
cell
infect
moi
transfect
h
later
indic
construct
analyz
express
h
thereaft
lane
control
whole
cell
extract
prepar
cell
either
mock
infect
lane
infect
sarscov
lane
analyz
posit
molecular
weight
marker
shown
right
gel
kda
express
sarscov
infect
cell
readili
detect
expect
size
kda
fig
lane
addit
potenti
defect
pcdna
construct
low
transfect
effici
flaw
could
exclud
sinc
pcdna
induc
high
level
express
rna
polymeras
promot
rna
polymeras
express
vero
cell
superinfect
recombin
vaccinia
viru
fig
lane
contrast
protein
express
could
detect
vero
cell
transfect
pci
construct
fig
lane
similar
data
obtain
cell
see
fig
pci
construct
differ
markedli
pcdna
construct
presenc
chimer
intron
cmv
promot
code
sequenc
insert
intron
compos
donor
site
first
intron
human
gene
branch
acceptor
site
intron
immunoglobulin
gene
promega
januari
revis
date
result
suggest
presenc
intron
requir
express
sarscov
gene
correspond
mrna
synthes
nucleu
transfect
cell
howev
express
level
driven
pci
remain
low
compar
level
observ
rna
polymeras
base
express
system
fig
compar
lane
latter
fuerst
et
al
transcript
take
place
primarili
cytoplasm
suggest
mrna
might
abnorm
process
synthesi
nucleu
ineffici
export
cytoplasm
cisact
viral
export
element
cte
masonpf
monkey
viru
mpmvcte
pre
woodchuck
hepat
viru
wpre
shown
increas
nuclear
export
mrna
result
higher
protein
express
level
bray
et
al
donello
et
al
gruter
et
al
popa
et
al
therefor
mpmvcte
wpre
sequenc
insert
pcdna
pci
plasmid
downstream
code
sequenc
upstream
polyadenyl
sequenc
fig
immunoblot
analysi
cell
lysat
prepar
transfect
cell
shown
fig
c
respect
express
remain
detect
level
whatev
viral
export
element
insert
pcdna
plasmid
mark
contrast
cte
wpre
increas
express
insert
pci
plasmid
dramat
effect
observ
upon
pciswpr
transfect
either
cell
similar
data
obtain
simian
hamster
bhk
cell
data
shown
evalu
accur
impact
cte
wpre
product
protein
express
level
quantifi
luminesc
signal
record
cool
ccd
camera
tabl
compar
pci
increas
wprecontain
pci
plasmid
observ
regardless
cell
line
use
cte
impact
express
cell
increas
cell
increas
express
cell
surfac
examin
fac
analysi
perform
nonpermeabil
cell
h
posttransfect
less
cell
transfect
either
plasmid
pcdna
seri
stain
polyclon
mous
anti
antibodi
fig
upper
left
panel
data
shown
cell
transfect
pciswpr
construct
found
posit
fig
lower
right
panel
agreement
immunoblot
data
wpre
much
effici
cte
enhanc
express
pci
dna
surfac
cell
level
produc
upon
transfect
pcisct
pciswpr
higher
respect
produc
upon
transfect
pci
analyz
whether
enhanc
express
correl
increas
mrna
level
perform
northern
blot
analysi
cytoplasm
fraction
prepar
h
posttransfect
cell
mrna
detect
mixtur
three
sspecif
probe
rel
abund
calcul
use
mrna
level
intern
control
repres
experi
shown
fig
mrna
prepar
h
transfect
cell
sspecif
mrna
detect
cytoplasm
cell
transfect
pcdnasderiv
plasmid
empti
plasmid
agreement
lack
express
mrna
expect
size
observ
plasmid
pci
seri
thu
cytoplasm
accumul
mrna
henc
protein
express
appear
depend
correct
splice
surprisingli
cte
impact
amount
cytoplasm
mrna
cell
neither
h
h
posttransfect
fig
data
shown
contrast
wpre
increas
mrna
level
cell
h
data
shown
h
fig
posttransfect
transient
increas
mrna
level
cell
h
posttransfect
fold
increas
data
shown
altogeth
result
show
cte
wpre
greater
effect
protein
level
mrna
level
compar
fig
tabl
fig
thu
promot
sarscov
spike
protein
express
increas
mrna
translat
cell
line
examin
impact
wpre
protein
express
consist
better
cte
reflect
synergist
effect
element
cytoplasm
mrna
level
mrna
translat
h
posttransfect
cytoplasm
rna
prepar
analys
northern
blot
presenc
mrna
mixtur
neg
sens
riboprob
specif
sequenc
describ
materi
method
posit
molecular
weight
marker
indic
side
normal
northern
blot
analysi
perform
parallel
use
neg
sens
specif
riboprob
amount
specif
rna
expect
size
star
rna
quantifi
calcul
specif
mrna
ratio
indic
imag
ratio
found
pci
transfect
cell
shown
sarscov
protein
effici
express
cell
surfac
use
wpre
element
sought
test
whether
protein
express
system
function
antigen
relev
first
evalu
capac
wpreexpress
protein
induc
receptordepend
celltocel
fusion
took
advantag
fact
experiment
condit
cotransfect
cell
two
differ
express
plasmid
allow
express
encod
protein
transfect
cell
popul
data
shown
thu
target
cell
prepar
cotransfect
cell
pcdnadsr
allow
express
fluoresc
dsred
protein
sarscov
receptor
respect
concurr
effector
cell
prepar
transfect
cell
pciswpr
plasmid
fusion
cocultur
green
effector
cell
red
target
cell
evalu
fac
analysi
fig
found
celltocel
fusion
occur
sexpress
effector
cell
mix
mocktransfect
target
cell
panel
b
mocktransfect
effector
cell
mix
target
cell
panel
c
percentag
greenand
redstain
cell
increas
background
panel
contrast
target
cell
express
fuse
effector
cell
express
panel
next
evalu
antigen
wpreexpress
protein
use
convalesc
human
sera
cell
transfect
pciswpr
pci
control
immunofluoresc
assay
ifa
carri
use
three
sar
convalesc
human
sera
two
normal
human
sera
fig
sexpress
cell
readili
stain
convalesc
sera
sar
case
panel
e
f
data
shown
sera
healthi
blood
donor
panel
exampl
control
vero
cell
show
stain
panel
b
addit
sprotein
base
ifa
allow
monitor
seroconvers
patient
sar
use
serum
sampl
taken
acut
convalesc
phase
diseas
panel
c
f
respect
exampl
altogeth
result
indic
wpremedi
express
qualit
quantit
relev
sinc
result
polypeptid
capabl
induc
celltocel
fusion
effici
recogn
convalesc
human
sera
order
compar
capac
cte
wpre
enhanc
efficaci
nake
dna
vaccin
perform
dose
respons
experi
femal
balbc
mice
immun
intramuscular
inject
pci
pcisct
pciswpr
nake
plasmid
dna
dose
rang
extend
suboptim
optim
dose
typic
plasmid
dna
vaccin
mice
select
accord
preliminari
experi
data
shown
publish
data
fu
et
al
ulmer
et
al
wang
et
al
control
group
mice
inject
dna
parent
pci
plasmid
mice
boost
week
dose
dna
result
immun
respons
analyz
week
later
anti
serum
igg
antibodi
titer
determin
individu
mice
indirect
elisa
use
sarscovinfect
cell
lysat
nativ
antigen
fig
optim
dose
three
express
plasmid
induc
high
anti
igg
respons
serum
igg
titer
pci
pciscteimmun
mice
pciswpreimmun
mice
indic
pciswpr
induc
significantli
higher
p
anti
igg
level
pci
pcisct
suboptim
dose
plasmid
dna
pciswpr
induc
much
higher
consist
respons
across
mice
titer
pci
titer
p
pcisct
titer
p
lowest
dose
plasmid
dna
per
mous
pci
pcisct
fail
induc
detect
anti
antibodi
titer
except
singl
mous
titer
eight
pciscteimmun
mice
wherea
anti
igg
titer
remain
high
titer
pciswpreimmun
mice
thu
anti
antibodi
level
induc
pcisct
compar
induc
pci
construct
statist
signific
differ
dose
test
p
dose
respons
experi
clearli
demonstr
wpre
strongli
enhanc
immunogen
sbase
antisar
nake
dna
vaccin
mice
wherea
cte
effect
remark
effect
observ
low
dose
nake
dna
per
mous
wpreenhanc
dna
vaccin
abl
induc
high
level
antisar
antibodi
assess
whether
low
dose
wpreenhanc
dna
vaccin
could
induc
protect
immun
sar
balbc
mice
inject
three
time
plasmid
dna
interv
mice
receiv
variou
dna
construct
describ
first
sera
sampl
week
postimmun
examin
whether
antibodi
respons
capabl
sarscov
neutral
neutral
antibodi
titer
remain
detect
level
fig
wpre
enhanc
anti
antibodi
respons
mice
immun
low
dose
plasmid
dna
group
balbc
mice
inject
twice
intramuscularli
interv
express
plasmid
dna
indic
pci
plasmid
dna
control
immun
sera
collect
week
second
inject
sarscov
specif
igg
antibodi
titer
determin
indirect
elisa
use
sarscov
infect
cell
lysat
captur
antigen
describ
materi
method
valu
individu
mous
repres
black
circl
mean
horizont
bar
detect
limit
assay
indic
dot
line
inject
either
pci
pcisct
plasmid
dna
fig
contrast
signific
level
sarscov
neutral
antibodi
measur
mice
immun
pciswpr
plasmid
dna
next
week
postimmun
mice
transfer
anim
facil
challeng
intranas
inocul
pfu
sarscov
viral
load
lung
evalu
day
later
fig
signific
differ
found
viral
titer
observ
mice
inject
pci
pfulung
pcisct
pfulung
control
pci
pfulung
sharp
contrast
immun
pciswpr
plasmid
dna
confer
almost
complet
protect
infecti
viru
detect
mice
pfu
lung
low
residu
titer
singl
mous
p
studi
clearli
indic
wpreenhanc
sar
dna
vaccin
effect
induc
complet
protect
immun
provid
protect
sarscov
challeng
lowdos
inject
nake
plasmid
dna
knowledg
vast
major
publish
studi
reli
transient
express
spike
protein
coronavirus
sarscov
epidem
recogn
involv
use
either
rna
polymerasebas
express
system
viral
express
vector
recombin
sindbi
vaccinia
virus
horsburgh
brown
krueger
et
al
narayanan
et
al
pulford
britton
vennema
et
al
yoo
deregt
may
indic
difficulti
express
effici
long
coronaviru
gene
follow
transient
transfect
mammalian
cell
convent
dna
express
vector
lead
mrna
synthesi
cell
nucleu
consist
hypothesi
also
found
sarscov
gene
express
detect
level
clone
classic
pcdna
mammalian
express
vector
control
nuclear
polymeras
ii
promot
fig
wherea
express
effici
recombin
vaccinia
viru
v
lorin
b
callendret
van
der
werf
n
escriou
unpublish
data
likewis
report
protein
sarscov
poorli
express
follow
dna
transfect
chang
et
al
hofmann
et
al
qin
et
al
simmon
et
al
henc
publish
studi
use
rna
polymerasebas
express
system
schwegmannwessel
et
al
xiao
et
al
synthet
gene
optim
human
codon
usag
qin
et
al
zhi
et
al
describ
design
use
modifi
dna
express
vector
enhanc
sarscov
express
mammalian
cell
dna
vector
contain
cmv
immediateearli
promot
chimer
intron
cisact
cte
wpre
element
demonstr
vector
permit
express
high
level
cell
surfac
transient
transfect
cell
compat
function
antigen
character
protein
addit
lowcost
easytous
express
vector
allow
us
develop
celltocel
fusion
assay
immunofluoresc
assay
may
prove
use
studi
cellular
viral
determin
sinduc
membran
fusion
sensit
specif
routin
diagnosi
sar
seroconvers
detect
express
spike
mrna
protein
transfect
cell
requir
use
plasmid
vector
contain
fig
wpre
requir
protect
mice
sarscov
challeng
upon
immun
lowdos
plasmid
dna
group
balbc
mice
inject
three
time
intramuscularli
interv
express
plasmid
dna
indic
pci
plasmid
dna
control
immun
sera
collect
week
third
inject
assay
neutral
antibodi
sarscov
neutral
titer
calcul
reciproc
highest
dilut
individu
serum
complet
prevent
sarscov
cpe
well
describ
materi
method
eight
week
third
dna
inject
mice
challeng
intranas
sarscov
pfumous
two
day
inocul
mice
euthan
lung
homogen
prepar
titrat
infecti
sarscov
plaqu
assay
cell
viral
titer
express
log
pfulung
individu
mice
b
valu
individu
mous
repres
black
circl
mean
horizont
bar
detect
limit
assay
indic
dot
line
data
shown
one
experi
repres
two
intron
upstream
orf
fig
find
consist
data
report
hofmann
et
al
simmon
et
al
broer
et
al
employ
pcagg
phcmv
vector
achiev
detect
express
pcagg
phcmv
vector
also
harbor
donor
acceptor
splice
site
downstream
polymeras
ii
promot
altogeth
data
indic
cytoplasm
accumul
mrna
henc
protein
express
absolut
depend
splice
gene
higher
eucaryot
contain
least
one
intron
mani
studi
clearli
shown
constitut
splice
intron
presenc
heterolog
intron
either
viral
cellular
origin
may
requir
optim
gene
express
varieti
system
includ
transient
express
mammalian
tissu
cultur
cell
import
splice
express
given
gene
appear
depend
sever
factor
intron
exon
ident
cell
type
buchman
berg
petitclerc
et
al
albeit
much
less
document
express
intronless
gene
bacteri
viral
origin
also
enhanc
includ
intron
within
mammalian
vector
huang
gorman
huang
yen
although
suggest
intron
alter
nucleocytoplasm
distribut
mrna
recent
data
indic
splice
rather
enhanc
mrna
product
translat
effici
lu
cullen
nott
et
al
result
extend
observ
indic
nuclear
express
natur
intronless
gene
deriv
rna
virus
replic
cell
cytoplasm
may
follow
requir
presenc
intron
effici
mrna
accumul
cytoplasm
although
cisact
viral
export
element
could
compens
lack
intron
express
human
cdna
retrovir
vector
cte
wpre
permit
effici
express
sarscov
gene
pcdna
vector
mrna
protein
remain
undetect
howev
remark
boost
express
observ
cte
wpre
combin
intron
within
pci
vector
fig
interestingli
observ
effect
cte
level
mrna
product
cell
unexpect
cteenhanc
express
link
ctemedi
export
mrna
confer
revindepend
gag
express
bray
et
al
contribut
overcom
inhibitori
element
mrna
tan
et
al
result
rather
support
hypothesi
rais
schambach
et
al
accord
cte
much
effici
promot
export
unsplic
introncontain
retrovir
rna
transcript
ernst
et
al
gruter
et
al
kang
cullen
facilit
transport
splice
mrna
contrast
wpre
enhanc
cytoplasm
mrna
level
cell
cte
wpre
export
function
differ
mechan
involv
cte
bind
tap
nuclear
mrna
export
factor
gruter
et
al
wpre
recruit
cellular
rna
export
factor
popa
et
al
observ
tap
also
implic
export
cellular
splice
mrna
nucleu
suggest
cte
rna
splice
mrna
share
common
nuclear
export
pathway
braun
et
al
may
explain
absenc
synergi
intron
cte
enhanc
cytoplasm
level
splice
mrna
cell
fig
contrast
wpre
rna
splice
mrna
use
differ
factor
nuclear
export
data
indic
may
act
synergist
enhanc
cytoplasm
express
introncontain
wpre
rna
fig
similar
observ
made
schambach
et
al
report
elev
express
human
multidrug
resist
gene
mrna
cell
depend
presenc
intron
wpre
effect
cte
wpre
pronounc
protein
level
cytoplasm
mrna
level
compar
fig
tabl
fig
indic
addit
initi
recogn
role
mrna
export
cte
wpre
also
act
promot
effici
mrna
translat
role
cte
mrna
translat
recent
suggest
group
borislawri
coyl
et
al
hull
borislawri
jin
et
al
contrast
full
agreement
common
view
wpre
exert
effect
protein
express
mainli
enhanc
mrna
process
nucleocytoplasm
transport
donello
et
al
loeb
et
al
zufferey
et
al
knowledg
singl
report
suggest
wpre
may
contribut
enhanc
cytoplasm
util
intronless
egfp
mrna
addit
effect
nuclear
rna
process
rna
export
interestingli
close
relat
hepat
b
viru
pre
also
report
enhanc
translat
rna
harbor
element
lu
cullen
conclus
vitro
studi
demonstr
mark
enhanc
effect
wpre
protein
express
splice
transcript
due
synergist
effect
increas
level
cytoplasm
messeng
rna
increas
cytoplasm
util
mrna
data
provid
like
explan
observ
wang
et
al
report
wpre
improv
product
protein
type
bovin
diarrhea
viru
cytoplasm
rna
viru
express
transient
transfect
cell
recombin
herpesviru
result
import
implic
construct
plasmid
viral
vector
optim
design
express
intronless
gene
cytoplasm
rna
virus
success
express
fulllength
protein
mammalian
cell
altern
achiev
other
use
codonoptim
synthet
gene
qin
et
al
zhi
et
al
codonusag
adapt
often
involv
substitut
nearli
everi
wobbl
posit
g
c
nucleotid
nakamura
octob
post
date
nakamura
et
al
result
gene
much
divers
nucleotid
composit
decreas
content
wildtyp
gene
virus
nuclear
life
cycl
contain
regulatori
element
evolv
inhibit
mrna
cytoplasm
accumul
gag
vpu
vif
graf
et
al
kotsopoul
et
al
nguyen
et
al
protein
collier
et
al
oberg
et
al
codon
optim
correspond
gene
shown
result
inactiv
element
thu
lead
increas
viral
protein
express
nuclear
dna
express
vector
cytoplasm
virus
sarscov
may
contain
cryptic
splice
site
mrna
instabl
motif
urich
element
are
put
cisact
inhibitori
sequenc
may
explain
dna
vectorbas
express
gene
virus
depend
presenc
heterolog
intron
transport
element
hypothes
codonusag
adapt
success
strategi
express
high
level
cytoplasm
viru
protein
result
remov
yet
uncharacter
inhibitori
element
sbase
dna
vaccin
experi
found
presenc
intron
mandatori
induc
high
titer
protect
neutral
antibodi
immun
mice
data
shown
agreement
absenc
polypeptid
express
cultur
cell
pcdna
plasmid
fig
weak
antibodi
respons
observ
other
mice
immun
pcdnabas
construct
wang
et
al
addit
among
publish
report
describ
fulllengthsbas
dna
vaccin
base
codonoptim
gene
prove
capabl
induc
high
titer
neutral
antibodi
mice
yi
et
al
rabbit
wang
et
al
noteworthi
similar
observ
report
recent
replicationdefect
human
adenovir
vector
contain
wildtyp
gene
control
cmv
promot
recombin
vector
fail
induc
cellular
immun
respons
spike
epitop
wherea
vector
encod
codonoptim
protein
prove
potent
immunogen
zhi
et
al
sinc
express
adenovir
vector
reli
nuclear
transcript
foreign
gene
corrobor
hypothesi
wildtyp
mrna
accumul
cytoplasm
absenc
heterolog
intron
present
studi
demonstr
combin
intron
wpre
intron
cte
act
synergist
enhanc
immunogen
sbase
antisar
dna
vaccin
balbc
mice
show
pciswpr
induc
sarscov
neutral
antibodi
respons
log
titer
similar
induc
codonoptim
express
vector
describ
yang
et
al
moreov
vivo
data
clearli
indic
immun
wpreenhanc
vaccin
induc
complet
protect
immun
challeng
infect
sarscov
dose
low
convent
dna
vaccin
includ
intron
sequenc
lack
wpre
fig
knowledg
first
report
success
dna
vaccin
protocol
use
fulllength
wildtyp
gene
sarscov
without
codon
optim
whether
wpre
could
enhanc
protect
efficaci
dna
vaccin
base
codonoptim
gene
sarscov
protein
report
yang
et
al
interest
question
would
deserv
addit
studi
report
recent
presenc
wpre
also
markedli
enhanc
efficaci
two
dna
vaccin
viral
vaccin
base
ha
express
mous
model
influenza
garg
et
al
well
tumor
vaccin
mous
model
neuroblastoma
metastas
pertl
et
al
three
studi
sar
studi
influenza
garg
et
al
neuroblastoma
pertl
et
al
model
show
remark
complementar
demonstr
wpre
enhanc
protect
efficaci
dna
vaccin
encod
antigen
fullyspl
cdna
tumor
gene
two
natur
intronless
gene
one
deriv
nucleusrepl
neg
strand
rna
viru
influenza
viru
cytoplasmrepl
posit
strand
rna
viru
sarscov
mechan
involv
enhanc
induct
protect
immun
remain
stricto
sensu
investig
wpre
like
improv
level
antigen
express
vivo
vitro
transient
transfect
experi
summari
data
provid
valuabl
inform
respect
improv
protein
express
wildtyp
sarscov
gene
use
intron
wpre
posttranscript
enhanc
result
improv
immunogen
sbase
dna
vaccin
practic
point
view
may
help
decreas
amount
plasmid
dna
immun
protocol
note
other
garg
et
al
lower
amount
dna
use
immun
protocol
concern
rais
use
dna
vaccin
risk
pose
integr
event
host
genom
induct
autoimmun
respons
cui
minim
moreov
one
princip
limit
dna
vaccin
efficaci
larg
anim
like
nonhuman
primat
may
relat
limit
distribut
dna
within
inject
tissu
limit
uptak
nucleu
follow
inject
dna
vaccin
rel
small
volum
dupui
et
al
otten
et
al
limit
may
circumv
use
effici
dna
vector
base
combin
intron
wpre
enhanc
describ
thu
improv
plasmid
vector
might
possibl
contribut
develop
safe
effici
dna
vaccin
sar
human
studi
larger
anim
cynomolgu
macaqu
african
green
monkey
recent
describ
suitabl
anim
model
sar
lawler
et
al
mcauliff
et
al
row
et
al
could
help
valid
intron
wpre
base
vector
fetal
rhesu
monkey
kidney
vero
african
green
monkey
kidney
cell
grown
co
complet
dmem
dulbecco
modifi
eagl
medium
mgml
lglucos
uml
penicillin
streptomycin
supplement
heatinactiv
fetal
calf
serum
fc
human
kidney
cell
grown
complet
dmem
supplement
fc
sarscov
strain
kindli
provid
hw
doerr
institut
medic
virolog
frankfurt
univers
medic
school
germani
viral
stock
produc
passag
vero
cell
cultur
multipl
infect
moi
complet
dmem
fc
viral
stock
store
titrat
standard
limit
dilut
assay
vero
cell
monolay
microtit
plate
infecti
titer
determin
tissu
cultur
infect
dose
accord
reed
muench
reed
muench
work
involv
infecti
sarscov
perform
enhanc
biosafeti
level
contain
laboratori
rigor
safeti
procedur
accord
guidelin
recombin
vaccinia
viru
encod
rna
polymeras
fuerst
et
al
provid
b
moss
nation
institut
health
bethesda
usa
propag
passag
monolay
moi
titrat
standard
plaqu
assay
gene
sarscov
obtain
directli
viral
rna
extract
qiaamp
viral
rna
mini
kit
qiagen
bronchoalveolar
lavag
specimen
patient
hospit
diagnosi
probabl
sar
french
hospit
vietnam
briefli
revers
transcript
rna
overlap
cdna
fragment
produc
nest
pcr
cdna
fragment
repres
complet
gene
sequenc
nt
assembl
clone
harbor
consensu
protein
sequenc
deduc
direct
sequenc
amplicon
specimen
nal
et
al
result
plasmid
psarss
use
sourc
cdna
subsequ
clone
mammalian
express
vector
comparison
sequenc
sequenc
genbank
access
urbani
genbank
access
isol
reveal
one
aminoacid
differ
posit
alanin
serin
urbani
dna
sequenc
code
protein
amplifi
pcr
pwo
polymeras
roch
use
psarss
plasmid
templat
oligonucleotid
ccatgtttat
tttcttatta
tttcttactc
tatgtgtaat
gtaatttgac
contain
bamhi
xhoi
restrict
site
digest
bamhi
xhoi
result
dna
fragment
insert
correspond
site
vector
invitrogen
yield
plasmid
pcdna
next
insert
subclon
nhei
xhoi
site
pci
plasmid
promega
yield
plasmid
pci
plasmid
contain
constitut
transport
element
mazonpf
monkey
viru
cte
ernst
et
al
postregulatori
element
woodchuck
hepat
viru
wpre
donello
et
al
kindli
provid
jacob
p
charneau
respect
institut
pasteur
pari
franc
cte
fragment
obtain
digest
relev
plasmid
xhoi
bamhi
wpre
fragment
obtain
digest
relev
plasmid
xhoi
kpni
fragment
insert
downstream
orf
sequenc
xhoi
xbai
site
either
pcdna
pci
plasmid
yield
plasmid
pcdnasct
pcdnaswpr
pcisct
pciswpr
respect
construct
insert
verifi
sequenc
posit
clone
use
big
dye
termin
sequenc
kit
autom
sequenc
appli
biosystem
cdna
encod
amino
acid
protein
amplifi
pcr
use
plasmid
templat
oligonucleotid
tgaccttgac
cggtgcacca
taatatattg
ctcatatttt
contain
ndei
xmai
restrict
site
digest
ndei
xmai
result
dna
fragment
insert
correspond
site
bacteri
express
vector
roch
yield
plasmid
c
final
recombin
fragment
c
contain
extran
ntermin
polyhistidin
tag
construct
insert
confirm
dna
sequenc
use
big
dye
termin
sequenc
kit
autom
sequenc
appli
biosystem
exponenti
grow
cultur
escherichia
coli
cell
harbor
c
express
construct
induc
synthes
c
polypeptid
addit
mm
cell
allow
grow
h
condit
c
recombin
polypeptid
recov
inclus
bodi
cell
harvest
lyse
lysi
buffer
trishcl
ph
mm
edta
use
french
press
psi
inclus
bodi
cell
lysat
pellet
centrifug
min
wash
lysi
buffer
supplement
triton
mm
mm
trishcl
urea
ph
buffer
min
gentl
shake
final
resuspens
mm
trishcl
ph
c
protein
obtain
puriti
determin
sdspage
coomassi
blue
stain
new
zealand
white
rabbit
immun
intraderm
inocul
mg
recombin
c
polypeptid
emulsifi
incomplet
freund
adjuv
sigma
boost
twice
interv
follow
week
later
anoth
inject
recombin
c
polypeptid
purifi
sucros
gradient
wash
triton
immun
sera
collect
week
last
boost
antibodi
react
specif
protein
express
sarscov
infect
cell
anti
antibodi
also
rais
mice
ectodomain
protein
express
mammalian
cell
solubl
polypeptid
b
callendret
v
lorin
p
charneau
van
der
werf
n
escriou
unpublish
data
first
serum
sampl
sampl
collect
day
onset
symptom
patient
probabl
sar
accord
case
definit
octob
post
date
second
set
sera
consist
one
pair
sampl
collect
patient
b
probabl
sar
day
sampl
day
sampl
onset
symptom
patient
b
respiratori
tract
specimen
test
posit
sarsl
gene
nest
rtpcr
control
serum
sampl
collect
sar
epidem
obtain
healthi
blood
donor
serum
sampl
inactiv
two
cycl
heat
min
clarifi
centrifug
min
igg
antibodi
sarscov
present
serum
sampl
assay
indirect
elisa
use
crude
lysat
sarscov
infect
cell
coat
antigen
see
non
specif
bind
sera
sarscov
antigen
analysi
protein
express
transient
transfect
cell
vero
cell
cell
mm
petri
dish
ml
cultur
medium
respect
transfect
plasmid
dna
reagent
roch
accord
manufactur
instruct
incub
co
medium
replac
h
later
express
analyz
indic
time
western
blot
cytofluorometri
immunofluoresc
assay
altern
vero
cell
mm
petri
dish
infect
moi
transfect
h
later
either
pcdna
pcdna
plasmid
dna
describ
vero
cell
grown
cm
flask
infect
sarscov
strain
moi
incub
complet
dmem
supplement
fc
co
total
cell
lysat
prepar
h
infect
h
sarscov
infect
express
analyz
western
blot
western
blot
assay
total
cell
extract
harvest
h
posttransfect
laemmli
sampl
buffer
sampl
denatur
heat
min
sonic
protein
separ
electrophoresi
sdspolyacrylamid
prosiev
cambrex
gel
transfer
onto
pvdf
membran
amersham
membran
incub
unfat
milk
h
room
temperatur
prior
immunoblot
rabbit
anti
polyclon
antibodi
follow
incub
peroxydas
conjug
antirabbit
secondari
antibodi
amersham
immunoblot
reveal
enhanc
chemiluminesc
ecl
amersham
accord
manufactur
instruct
autoradiographi
hyperfilm
amersham
altern
luminesc
signal
captur
cool
ccd
camera
fluor
multimag
biorad
protein
express
level
quantifi
gel
imag
use
quantiti
one
softwar
v
biorad
cell
grown
dish
transfect
describ
h
posttransfect
cell
monolay
wash
twice
dpb
invitrogen
cellular
rna
prepar
total
cellular
rna
isol
trizol
extract
invitrogen
accord
manufactur
recommend
cytoplasm
rna
extract
cell
lyse
ice
mm
trishcl
ph
nacl
mm
mgcl
mm
dtt
min
incub
sampl
centrifug
min
rna
purifi
supernat
phenolchloroform
extract
isopropanol
precipit
rna
treat
dnase
use
dnafre
kit
ambion
accord
manufactur
recommend
store
use
denatur
formamid
formaldehyd
run
buffer
mm
mop
mm
sodium
acet
mm
edta
ph
sampl
run
formaldehyd
gel
blot
onto
nylon
membran
hybond
n
amersham
fix
uv
irradi
membran
hybrid
mixtur
neg
sens
sspecif
plabel
riboprob
correspond
nt
sarscov
genom
normal
membran
hybrid
riboprob
hybrid
perform
formamid
ssc
denhardt
sd
solut
membran
wash
time
ssc
sd
room
temperatur
anoth
time
ssc
sd
final
membran
expos
storm
phosphorimag
molecular
dynam
analyz
use
imag
quant
program
v
molecular
dynam
cytofluorometri
assay
subconflu
monolay
cell
cell
transfect
describ
h
posttransfect
cell
wash
dpb
detach
ml
cell
dissoci
solut
sigma
cell
stain
polyclon
mous
anti
antibodi
min
wash
incub
secondari
antibodi
antimous
fitcconjug
bd
bioscienc
pharmingen
min
cell
wash
fix
paraformaldehyd
event
acquir
facscalibur
fluorocytomet
beckton
dickinson
analyz
bd
cellquest
pro
softwar
v
beckton
dickinson
indirect
immunofluoresc
assay
subconflu
monolay
cell
transfect
describ
h
post
transfect
cell
dissoci
ml
cell
dissoci
solut
plate
mm
glass
coverslip
wellplat
incub
co
h
later
cell
wash
dpb
fix
paraformaldehyd
min
coverslip
incub
min
patient
serum
dilut
bsa
subsequ
incub
fitcconjug
antihuman
igg
secondari
antibodi
jackson
immunoresearch
sampl
mount
slide
dapicontain
vectashield
vector
laboratori
analyz
axioplan
epifluoresc
microscop
zeiss
pictur
acquir
axiocam
mrm
camera
process
axiovis
softwar
v
zeiss
plasmid
encod
molecul
receptor
sarscov
obtain
michael
r
farzan
cell
constitut
express
green
fluoresc
protein
obtain
transduct
cell
tripgfp
lentivir
vector
zennou
et
al
effector
cell
transfect
either
plasmid
encod
glycoprotein
pci
plasmid
control
describ
parallel
target
cell
cotransfect
dsred
plasmid
dna
either
pcdna
plasmid
dna
use
transfect
reagent
medium
replac
h
transfect
effector
target
cell
detach
h
later
cell
dissoci
solut
resuspend
fresh
count
per
well
target
effector
cell
plate
togeth
wellplat
ml
well
cocultur
h
co
cell
trypsin
fix
paraformaldehyd
analyz
facscalibur
fluorocytomet
fusion
measur
ratio
doublestain
red
target
cell
use
bd
cellquest
pro
softwar
femal
balbc
mice
cerj
week
age
hous
handl
accord
pasteur
institut
guidelin
complianc
european
anim
welfar
regul
mice
inject
intramuscularli
pb
tibiali
anterior
muscl
contain
plasmid
dna
mice
inject
either
pci
plasmid
dna
control
variabl
amount
pci
pcisct
pciswpr
plasmid
dna
booster
inject
administ
interv
dna
use
inject
prepar
use
endofre
plasmid
mega
kit
qiagen
test
absenc
endotoxin
eumg
measur
endotoxin
kit
biowhittak
blood
mice
collect
week
immun
week
inject
induct
sarscov
specif
antibodi
immun
mice
measur
indirect
elisa
neutral
assay
elisa
microtit
plate
coat
sarscov
infect
mockinfect
vero
crude
cell
lysat
prepar
mm
boric
acid
mm
nacl
triton
solut
ph
sonic
cuphorn
tip
clarifi
centrifug
min
inactiv
frozen
gamma
irradi
kgi
co
sourc
wash
tween
plate
incub
threefold
serial
dilut
mous
sera
dri
skim
milk
wv
start
bound
antibodi
reveal
horseradish
peroxidaseconjug
antimous
igg
secondari
antibodi
amersham
tmb
kpl
absorb
measur
nm
refer
wavelength
nm
read
well
coat
mock
lysat
substract
well
sarscov
lysat
sarscov
specif
igg
titer
calcul
reciproc
highest
dilut
individu
serum
give
absorb
differ
neutral
assay
twofold
serial
dilut
heatinactiv
min
serum
sampl
mix
sarscov
complet
dmem
incub
min
ad
subconflu
monolay
cell
microtit
plate
dilut
serum
well
posit
control
sarscov
neg
cell
control
test
quadrupl
cytopath
effect
cpe
endpoint
read
day
inocul
neutral
antibodi
titer
determin
accord
reed
muench
method
reed
muench
reciproc
highest
dilut
serum
suppress
cpe
least
well
eight
week
third
plasmid
dna
inject
mice
lightli
anaesthet
isofluran
mundipharma
inocul
intranas
pfu
sarscov
pb
mice
euthan
h
challeng
infect
whole
lung
crush
dmem
supplement
fc
use
glass
bead
mixer
mill
retsch
clarif
lowspe
centrifug
min
lung
homogen
titrat
infecti
viru
cell
monolay
standard
plaqu
assay
challeng
infect
mice
subsequ
analysi
done
jean
merieux
biosafeti
level
contain
laboratori
three
mice
die
transfer
facil
thu
could
challeng
statist
analysi
perform
viral
titer
measur
individu
mice
use
student
independ
ttest
assumpt
use
small
sampl
normal
distribut
variabl
varianc
popul
compar
loth
sandra
expert
technic
assist
perform
sarscov
challeng
experi
assist
staff
collabor
center
refer
research
influenza
respiratori
virus
institut
pasteur
pari
franc
initi
analysi
sar
specimen
sera
grate
acknowledg
work
support
part
grant
glaxosmithklin
biolog
biorad
laboratori
bc
support
fellowship
glaxosmithklin
biolog
